(Q40891332)

24 September 2017

1 reference

title

Clinical results with recombinant human interleukin-3. (English)

1 reference

24 September 2017

0 references

Ganser A

1

1 reference

24 September 2017

publication date

1 January 1993

1 reference

24 September 2017

1 reference

24 September 2017

volume

11

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

212-218

1 reference

Hematopoietic growth factors. Biology and clinical applications

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Interleukin 3-dependent mediator release in basophils triggered by C5a.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Interleukin 3 activates human blood basophils via high-affinity binding sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Definition of a population of CD4-8- T cells that express the alpha beta T-cell receptor and respond to interleukins 2, 3, and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Replacement of the cytoplasmic domain alters sorting of a viral glycoprotein in polarized cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Effect of recombinant and purified human haematopoietic growth factors on in vitro colony formation by enriched populations of human megakaryocyte progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Stimulation of hematopoiesis in vivo by recombinant bacterial murine interleukin 3

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1, recombinant murine interleukin 3, and recombinant murine granulocyte/macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

Production of the haemopoietic growth factors GM-CSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909309024841

10.3109/07357909309024841

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference